TP53 and cancer: Given that most malignant tumors are deficient in p53, the Achilles heel of tumor suppression via telomere erosion in humans is perhaps loss of p53, resulting in failure to impose cell cycle arrest or apoptosis when telomeres are too short (6, 8, 76).